The Abnormal Glucose Tolerance Treatment market was valued at USD 214.30 Million in 2024 and is expected to reach USD 340.02 Million by 2032, growing at a CAGR of 5.94% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.